Strategic Partnerships Leverage Repertoire’s recent Genentech collaboration and Bristol Myers Squibb tolerizing vaccine deals to position co-development partnerships with pharma focusing on autoimmune and cancer therapies, highlighting a proven appetite for alliance models and milestone-driven funding.

TCR Platform Value Target opportunities around DECODE platform capabilities that map T cell receptor-epitope interactions, offering differentiated assets for autoimmune, infectious diseases, and oncology programs to accelerate target validation and reduce development risk.

Clinical Leadership With a new Chief Medical Officer appointment, approach opportunities that benefit from stronger clinical strategy and trial execution, including advisory roles, co-development planning, and early-phase program design support.

Financial Capacity Capitalize on substantial funding and projected milestone payments to propose large, multi-phase collaborations, providing funding visibility for joint programs and enabling accelerated clinical timelines.

Global Reach Engage across Cambridge and Zurich operations to target regional talent, CRO networks, and regulatory pathways, while aligning global development and manufacturing strategies to support scalable, multinational trials.